Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

HA-gel-dex hydrogels help heal wounds and regenerate tissue effectively.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride may help shrink prostate cancer tumors.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Physical activity, height, and smoking affect prostate cancer risk.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride helps reduce blood vessel growth in diabetic rat kidneys.

Taking finasteride before surgery reduces blood loss in prostate procedures.